Elementis (LON:ELM) Stock Passes Above 200 Day Moving Average – Here’s Why
by Mitch Edgeman · The Markets DailyShares of Elementis plc (LON:ELM – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 163.60 and traded as high as GBX 168. Elementis shares last traded at GBX 166, with a volume of 125,149 shares changing hands.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group restated a “buy” rating and set a GBX 200 price target on shares of Elementis in a research note on Thursday, October 23rd. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of GBX 185.
Read Our Latest Stock Analysis on Elementis
Elementis Stock Down 0.7%
The company has a fifty day simple moving average of GBX 163.11 and a 200-day simple moving average of GBX 163.62. The company has a quick ratio of 1.16, a current ratio of 2.04 and a debt-to-equity ratio of 37.85. The firm has a market cap of £945.35 million, a P/E ratio of -12.97, a price-to-earnings-growth ratio of 3.05 and a beta of 2.02.
Insider Activity
In related news, insider Luc van Ravenstein acquired 16,850 shares of the business’s stock in a transaction that occurred on Thursday, November 20th. The stock was bought at an average cost of GBX 156 per share, for a total transaction of £26,286. Company insiders own 1.81% of the company’s stock.
Elementis Company Profile
Elementis is a global specialty chemicals company. We offer performance-driven additives that help create innovative formulations for consumer and industrial applications. As a FTSE 250 company, listed on the London Stock Exchange, we employ c.1,030 people globally. We have a nearly 200-year tradition of creating ingredients that add value to everyday consumer and industrial products. In 2024 Elementis reported revenue of $738m and adjusted operating profit of $129m.
Further Reading
- Five stocks we like better than Elementis
- With a $7 Valuation, NNVC Could Disrupt the Biotech Space in 2026
- BNZI Posts Record Q3 Revenue – See What’s Driving It.
- Do you know what Amazon is planning for January 1?
- Turn your “dead money” into $306+ monthly (starting this month)
- [How To] Claim Your Pre-IPO Stake In SpaceX!